Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PYGB | P11216 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16285372 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL2429112 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL19603336 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL5862474 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL3144972 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL4703623 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL8361874 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22026379 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL22047951 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 | |
| SCHEMBL3144958 | 1.00 | SLC28A3 (0.50) | SLC28A3L3MBTL1MAPTPYGBLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957360-B | Acetyl glycoside orange ketone and anti-tumor application | 中国科学院新疆理化技术研究所 | 2023-12-19 | — | — | CN | claimed |
| CN-114957360-A | Acetyl glycoside aurone and anti-tumor application | 中国科学院新疆理化技术研究所 | 2022-08-30 | — | — | CN | claimed |
| CN-110343155-B | Vaccinium myrtillus fruit acetylated anthocyanin specific transporter VcMATE2 | 吉林农业大学 | 2022-08-12 | — | — | CN | claimed |
| CN-111205343-B | Nitrogen acetyl glucoside or galactoside compound of epothilone B, and enzymatic preparation and application thereof | 山东大学 | 2022-06-14 | — | — | CN | claimed |
| CN-112125940-A | Cosmetic containing tetraacetyl glucoside modified phloretin and preparation method thereof | 青岛姿之妍化妆品科技有限责任公司 | 2020-12-25 | — | — | CN | claimed |
| CN-110997917-A | Nucleic acid, composition containing nucleic acid, conjugate, preparation method and application | 苏州瑞博生物技术有限公司 | 2020-04-10 | — | — | CN | claimed |
| EP-1545206-B1 | COMPOSITIONS AND PRODUCTS CONTAINING ENANTIOMERIC EQUOL, AND METHODS FOR THEIR MAKING | CHILDRENS HOSPITAL MED CT (US) | 2020-03-04 | — | — | EP | claimed |
| EP-3436820-A2 | DETECTING MICROBIAL INFECTION IN WOUNDS | Qualizyme Diagnostics GmbH&Co KG (AT) | 2019-02-06 | — | — | EP | claimed |
| US-20180305389-A1 | BRANCHED ALCOHOL-BASED SUGAR SURFACTANTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-10-25 | — | — | US | claimed |
| EP-2485740-B1 | METHODS FOR PREVENTING OR TREATING SARCOPENIA AND MUSCLE ATROPHY IN ANIMALS | NESTEC SA (CH) | 2018-08-29 | — | — | EP | claimed |
| US-7396855-B2 | Compositions and products containing S-equol, and methods for their making | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2008-07-08 | — | — | US | claimed |
| EP-1545206-A4 | COMPOSITIONS AND PRODUCTS CONTAINING ENANTIOMERIC EQUOL, AND METHODS FOR THEIR MAKING | CHILDRENS HOSP MEDICAL CENTER (US) | 2006-10-04 | — | — | EP | claimed |
| CN-1681386-A | Compositions and products containing enantiomeric equol and methods of making the same | CHILDRENS HOSP MEDICAL CT (US) | 2005-10-12 | — | — | CN | claimed |
| EP-1545206-A2 | COMPOSITIONS AND PRODUCTS CONTAINING ENANTIOMERIC EQUOL, AND METHODS FOR THEIR MAKING | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2005-06-29 | — | — | EP | claimed |
| US-20040235758-A1 | Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery | AUSTRALIAN HEALTH & NUTRITION ASSOCIATION LIMITED (AU) | 2004-11-25 | — | — | US | claimed |
| US-20040147594-A1 | Food; skin disorders; drugs; supplying to mammals ; topical applying to skin; oral administering; hormone replacement therapy; anticancer agents | SETCHELL KENNETH DAVID REGINAL | 2004-07-29 | — | — | US | claimed |
| WO-2004009035-A2 | COMPOSITIONS AND PRODUCTS CONTAINING ENANTIOMERIC EQUOL, AND METHODS FOR THEIR MAKING | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2004-01-29 | — | — | WO | claimed |
| WO-2003051864-A1 | ISOFLAVONOID CONJUGATES, COMPOSITIONS THEREOF AND THERAPEUTIC METHODS INVOLVING SAME | NOVOGEN RESEARCH PTY LTD (AU) | 2003-06-26 | — | — | WO | claimed |
| EP-1118667-A1 | NOVEL ENZYME COMPOSITIONS, PROCESS FOR PRODUCING THE SAME AND UTILIZATION OF THE SAME | Amano Enzyme Inc. (JP) | 2001-07-25 | — | — | EP | claimed |
| US-4331802-A | Organometallic reagents and their use in the synthesis of cardenolides and isocardenolides | ADVANCE BIOFACTURES CORPORATION (US) | 1982-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305389-A1 | BRANCHED ALCOHOL-BASED SUGAR SURFACTANTS | B3GAT3, GANAB, ST6GAL1 | SLC28A3 2332/4885L3MBTL1 1986/4885MAPT 2898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.